Physician profile
John Lyon
NPI 1336208305
$2,046.42
in general payments reported to CMS, 2019-2025
16 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2021: $217 · 2022: $429 · 2023: $395 · 2024: $473 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215 · Entertainment: $20.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.31 |
| Entertainment | $20.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.42 | 2022-2025 | |
| Alcon Vision LLC | $446.64 | 2019-2024 | Argos, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $277.24 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Astellas Pharma US INC | $148.17 | 2023-2025 | Izervay |
| Ocular Therapeutix, INC. | $147.22 | 2023-2025 | Dextenza |
| Ivantis, INC | $91.92 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $51.51 | 2021 | |
| Allergan, INC. | $44.88 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $40.84 | 2021 | |
| Oyster Point Pharma, INC. | $26.52 | 2023 | Tyrvaya |
| Optos, INC. | $20.81 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $20.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $16.35 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $16.29 | 2023 | Acthar |
| Sight Sciences, INC. | $13.96 | 2025 | Omni Surgical System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $13.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.